Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models

导出原文传递

翻译打印收藏纠错

作者： Benmebarek, M. ^[1] ; Karches, C. H. ^[2] ; Schmidbauer, M. L. ^[3] ; Kurzay, M. ^[4] ; Klaus, R. ^[5] ; Geiger, M. ; Rataj, F. ; Cadilha, B. ; Lesch, S. ; Heise, C. ; Murr, R. ; vom Berg, J. ; Jastroch, M. ; Lamp, D. ; Niederfellner, G. ; Sustmann, C. ; Endres, S. ; Klein, C. ; Kobold, S.

作者单位： Div Clin Pharmacol, Munich, Germany ^[1] Roche Innovat Ctr Munich, Penzberg, Germany ^[2] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Neuherberg, Germany ^[3] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland ^[4] Roche Innovat Ctr Zurich, Schlieren, Switzerland ^[5]

发布时间 2020-04-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

European journal of cancer

2019年110卷

S3-S3页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models

European journal of cancer

相似文献

European journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models

European journal of cancer

相似文献

European journal of cancer

相关期刊

检索历史清除